You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: August 14, 2024

TECHNESCAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Technescan patents expire, and when can generic versions of Technescan launch?

Technescan is a drug marketed by Curium and Draximage and is included in five NDAs.

The generic ingredient in TECHNESCAN is technetium tc-99m pyrophosphate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m pyrophosphate kit profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TECHNESCAN?
  • What are the global sales for TECHNESCAN?
  • What is Average Wholesale Price for TECHNESCAN?
Summary for TECHNESCAN
Drug patent expirations by year for TECHNESCAN

US Patents and Regulatory Information for TECHNESCAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Curium TECHNESCAN MAG3 technetium tc-99m mertiatide kit INJECTABLE;INJECTION 019882-001 Jun 15, 1990 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Draximage TECHNESCAN GLUCEPTATE technetium tc-99m gluceptate kit INJECTABLE;INJECTION 018272-001 Jan 27, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Draximage TECHNESCAN HIDA technetium tc-99m lidofenin kit INJECTABLE;INJECTION 018489-001 Oct 31, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Curium TECHNESCAN PYP KIT technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 017538-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TECHNESCAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TECHNESCAN

See the table below for patents covering TECHNESCAN around the world.

Country Patent Number Title Estimated Expiration
Ireland 48095 STABILIZED RADIOGRAPHIC SCANNING AGENTS AND METHOD FOR PREPARING THEM ⤷  Sign Up
South Africa 7903894 ⤷  Sign Up
Denmark 133979 ⤷  Sign Up
Japan H0149329 ⤷  Sign Up
Ireland 48927 COMPOSITIONS FOR USE AS RADIOGRAPHIC SCANNING AGENTS ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for TECHNESCAN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1178838 300736 Netherlands ⤷  Sign Up PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.